The glycolytic glucose utilization by tumor cells limits the glucose availability in the TME, impeding T cell infiltration and IFN-γ production as T cells highly depend on glycolysis for their differentiation and effector function [206, 207]. The gene discussed is IFNG; the disease is neoplasm.